Melanoma

September 22, 2014September 22, 2014

Decision Resources Group Survey Shows that Half of Oncologists Prescribe Tafinlar and Mekinist to Treat Melanoma

Melanoma, News

The consulting company Decision Resources Group, which analyzes critical issues within the healthcare industry, recently concluded that more than half of the surveyed U.S. oncologists prescribe GlaxoSmithKline‘s BRAF inhibitor Tafinlar for BRAF-mutation-positive unresectable or ... Read more

September 22, 2014September 22, 2014

Melanoma Risk Associated with Telomere Length, According to Study

Melanoma, News

Researchers from the University of Leeds, have published a new study entitled “The effect on melanoma risk of genes previously associated with telomere length,” published in the Journal of the National ... Read more

September 19, 2014September 19, 2014

12.1 Million NCI Grant Awarded For Melanoma Research at Wistar Institute

Melanoma

Melanoma research has been gaining a lot of momentum through a number of recent US FDA approvals and Orphan Drug Designations for highly promising, novel treatments for this fatal type ... Read more

September 16, 2014September 16, 2014

Study Shows Possible Link between Viagra and Risk for Melanoma

Melanoma, News

A study entitled “Sildenafil Use and Increased Risk of Incident Melanoma in US Men, A Prospective Cohort Study” and published in the JAMA Internal Medicine journal has shown that there ... Read more

September 15, 2014September 15, 2014

MD Anderson Co-hosts Night Fun Run for Melanoma

Melanoma, News

Melanoma, the most serious type of skin cancer, is expected to be diagnosed in over 76,000 new cases of skin cancer this year alone. In order to raise funds for much needed ... Read more

September 12, 2014September 12, 2014

Study Finds Link Between Genetic Mutation and Melanoma Progression

Melanoma, News

In a study entitled, “BRAFV600E melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity” published in the British Journal of Cancer, scientists from Dartmouth-Hitchcock Norris Cotton Cancer Center in ... Read more

September 11, 2014September 11, 2014

Myriad myPath Melanoma Reduces Indeterminate Diagnosis and May Correct Treatment Recommendations

Melanoma, News

Molecular diagnostic company Myriad Genetics recently presented the results of its pivotal clinical utility study of the Myriad myPath Melanoma test, a new diagnostic tool for determining if a tissue is a malignant melanoma or ... Read more

September 10, 2014September 10, 2014

Melanoma Diagnosis Part of New, Advanced Broad-Spectrum Cancer Detection and Monitoring Platform

Melanoma, News

Aethlon Medical, Inc. and its diagnostic subsidiary, Exosome Sciences, Inc. (ESI), have announced that ESI researchers developed and validated a lectin-based diagnostic platform that can isolate exosome-based biomarkers common to several ... Read more

September 9, 2014September 9, 2014

JAMA Dermatology Advocates Changes in Healthcare Melanoma Screening

Melanoma, News

The monthly peer-reviewed medical journal published by the American Medical Association recently advocated changes to the way the nation’s melanoma screens are performed within the healthcare system, considering that there is $2.85 billion in overall lost productivity to the entire economy, in ... Read more

September 8, 2014September 8, 2014

Melanoma Risk Higher for Flight Crews, According to Study

Melanoma, News

A new study entitled “The Risk of Melanoma in Airline Pilots and Cabin Crew” published in the JAMA Dermatology journal has found that pilots and cabin crew members are 2.22 ... Read more

September 4, 2014September 5, 2014

Breakthrough Melanoma Treatment Approved by FDA

Melanoma, News, Skin Cancer

It is estimated that roughly 5% of all newly diagnosed cancers in America are melanomas — a tumor of melanin-forming cells, and ranked as the most serious type of skin ... Read more

September 4, 2014September 4, 2014

New Handheld Device Allows Deeper Melanoma Screening

Melanoma, News

Researchers from Washington University in St. Louis have constructed a hand-held photoacoustic microscopy device that uses lasers and sound waves to measure how deep a melanoma tumor extends into the ... Read more

September 3, 2014September 3, 2014

Amgen Submits Marketing Authorization Application For New Melanoma Immunotherapy

Melanoma, News

Amgen, a biotechnology company developing innovative human therapeutics, has announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval for talimogene laherparepvec as a treatment ... Read more

August 29, 2014August 29, 2014

Macrophage Migration Inhibitory Factor Found To Be Prognostic Factor in Metastatic Melanoma

Melanoma, News

In a study entitled “Macrophage migration inhibitory factor engages PI3K/Akt signaling and is a prognostic factor in metastatic melanoma” published in the BMC Cancer journal, a group of researchers set ... Read more

August 27, 2014August 27, 2014

Experimental Melanoma Drug Trains Immune System To Fight Disease

Melanoma, News

Loyola University Medical Center in Chicago is currently enrolling melanoma patients in a Phase I clinical trial for an experimental immunotherapy vaccine. The treatment will consist of ex vivo collection ... Read more

August 26, 2014August 26, 2014

Merck’s Immuno-Oncology Melanoma Drug May Be On Track For FDA Approval

Melanoma, News

Merck & Co‘s novel immuno-oncology drug for melanoma, pembrolizumab, is about to be approved by the U.S. Food and Drug Administration, according to a news report released yesterday by Reuters, ... Read more

August 21, 2014August 21, 2014

Australian Researchers Investigate Patient, Tumor Characteristic Associations For High-Mitotic Rate Melanoma

Melanoma, News

A study by a team of Australian researchers has investigated patient and tumor characteristics for high-mitotic rate melanoma (high-mitonic is a marker of tumor cell growth) with the objective of increasing earlier ... Read more

August 18, 2014

Specialized Immune Cells That Kill Melanoma Cells Identified By Researchers

Melanoma

A team of researchers from the Walter and Eliza Hall Institute, Melbourne have found that  ​myeloid cell leukaemia sequence-1 (​Mcl1) is crucial for the survival of natural killer (NK) cells in vivo, ... Read more

August 15, 2014August 15, 2014

Breakthrough Melanoma Diagnosis Technology Could Save Patients from Unnecessary Biopsies

Melanoma, News

Just recently, Melanoma News Today reported on how a new device allowing an early non-invasive examination of melanoma and other skin cancer lesions has been developed by a team of researchers ... Read more

August 12, 2014August 12, 2014

Researchers Offer New Insight Into Adjuvant Therapy for Stage III Melanoma

Melanoma, News

Even though the incidence of malignant melanoma is increasing, the majority of cases are diagnosed at an early stage. In this setting, surgery is the best option, proving to be ... Read more